TACTILE SYSTEMS TECHNOLOGY INC (TCMD) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, TACTILE SYSTEMS TECHNOLOGY INC's filing signal turned positive.

Tactile Systems Technology, Inc. is a medical technology company focused on developing and providing at-home treatment solutions for underserved chronic diseases, primarily lymphedema and chronic respiratory conditions. The company's core offerings include the Flexitouch Plus, Entre Plus, and Nimbl pneumatic compression systems for lymphedema, and the AffloVest for airway clearance. Tactile Medical employs a direct-to-patient and provider model for its lymphedema products, managing referrals, insurance claims, and patient training, while utilizing a durable medical equipment (DME) distribution model for AffloVest. For the year ended December 31, 2025, the company generated $329.5 million in revenue, with lymphedema products accounting for 84% and AffloVest accounting for 16%. Tactile Medical operates exclusively within the United States.

Revenue is primarily driven by sales and rentals of its lymphedema product lines (Flexitouch Plus, Entre Plus, Nimbl) and sales of its AffloVest airway clearance device. Growth is supported by expanding its direct sales force, strategic partnerships with DME providers, and efforts to increase clinician and patient awareness.